Official UK procurement notice
Attention Deficit Hyperactivity Disorder (ADHD) and Autism Pathway services NHS North East and North Cumbria (Patient Choice)
Authority: NHS North East and North Cumbria Integrated Care Board (Central government)
What is being bought
Published requirement descriptionNHS North East and North Cumbria Integrated Care Board (NENC ICB) has awarded a contract for the provision of Attention Deficit Hyperactivity Disorder (ADHD) and Autism diagnostic and assessment pathway services under the patient choice Framework. The service includes assessment, diagnosis, post-diagnostic support, and associated clinical interventions delivered in accordance with relevant national guidance and local pathway requirements.
The contract has been awarded to NHS North East and North Cumbria Integrated Care Board following Direct Award Process B under the The Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 and Procurement Regulations 2024 do not apply to this award.
This contract covers ADHD and Autism diagnostic and treatment pathway services across the NENC ICB footprint.
The service operates on an activity-based tariff model. The estimated total value shown reflects the highest unit tariff for the purposes of system entry. Payment is made on an activity basis and there is no guaranteed minimum activity.
CPV: Health services
The lotProcurement structure
single lot · no lot value publishedLot #1The contract covers the provision of Attention Deficit Hyperactivity Disorder (ADHD)…Awarded
The contract covers the provision of Attention Deficit Hyperactivity Disorder (ADHD) and Autism diagnostic, assessment, and treatment pathway services for patients across the NHS North East and North Cumbria Integrated Care Board footprint. The contract will commence on 01 April 2026 for a period of three years, with the option to extend for an additional two years.
The relevant authority intends to award this contract under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 and Procurement Regulations 2024 do not apply to this award.
Contract start date: 01 April 2026
Contract end date: 31 March 2031
Payments are made on an activity-based tariff system, with charges applied upon completion of each assessment or activity.
This is an existing service.
This is a new provider.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 6 Mar 2026, 08:52 GMT
- Last source update
- 6 Mar 2026, 08:52 GMT
- FTS notice number
2026/S 000-020184- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0663a8Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
The relevant authority intends to award this contract under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 and Procurement Regulations 2024 do not apply to this award.
Publisher note: The relevant authority intends to award this contract under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 and Procurement Regulations 2024 do not apply to this award. Details of individual making decisions: Chief Contracting & Procurement Officer; Director of Contracting and Oversight (South); Deputy Director of Finance; Strategic Head of General Medical Contracting; Strategic Head of Procurement; Director of Nursing, Mental Health, Learning; Disabilities, Autism and Complex Care Director of Contracting & Oversight (North); and Director of Transformation, Mental Health, Learning Disability, neurodiversity and Wider determinants. There were no conflicts of interest identified.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| The Validium Group Limited t/a HealthHero Solutions | £1,500 † | — | Awarded |
Contracts
Contract 020184-2026-1 · The Validium Group Limited t/a HealthHero Solutions
- Signed
- 13 Feb 2026
- Value
- £1,500
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- The Validium Group Limited t/a HealthHero SolutionsAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.